<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37141321</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>5</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Norwegian version of the Edinburgh cognitive and behavioural ALS screen: Construct validity, internal consistency, inter-rater, and test-retest reliability.</ArticleTitle><Pagination><StartPage>e0285307</StartPage><MedlinePgn>e0285307</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0285307</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0285307</ELocationID><Abstract><AbstractText Label="BACKGROUND">Research collaboration highlight a need for validated tests in other languages than English. Translation and culture adjustments may threaten essential features of the original instrument.</AbstractText><AbstractText Label="OBJECTIVE">To assess the internal consistency, inter-rater and test-retest reliability, and construct validity of the Norwegian version of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis (ALS) Screen (ECAS-N).</AbstractText><AbstractText Label="METHODS">Performance of 71 subjects with ALS, 85 healthy controls (HC) and 6 controls with Alzheimer's disease (AD) were assessed with the ECAS-N. Test-retest interval was four months. Internal consistency was evaluated using Cronbach's alpha; reliability was assessed using intraclass correlation coefficient (ICC), Cohen's kappa, and Bland Altman plot. Five hypothesis, including the Montreal Cognitive Assessment (MoCA) screen, was evaluated for construct validity.</AbstractText><AbstractText Label="RESULTS">ECAS-N total score produced a Cronbach's alpha of 0.65, had excellent inter-rater reliability (ICC = 0.99) and acceptable test-retest reliability (ICC = 0.73). Construct validity analysis suggested valid use of the ECAS-N to distinguish people with ALS-specific cognitive impairment from HC (p = 0.001) and those with AD (p = 0.002). The MoCA and ECAS-N were moderately correlated (r = 0.53).</AbstractText><AbstractText Label="CONCLUSION">The ECAS-N has potential to be used by different testers in clinical practice and research to screen patients with ALS who speak Norwegian and for documenting cognitive impairment over time.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Taule et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taule</LastName><ForeName>Tina</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-9094-347X</Identifier><AffiliationInfo><Affiliation>Department of Occupational Therapy, Orthopedic Clinic, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eide</LastName><ForeName>Irmelin Smith</ForeName><Initials>IS</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Services, Haraldsplass Deaconess Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fj&#xe6;r</LastName><ForeName>Line</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Physio and Occupational Therapy, Namsos hospital, Nord-Tr&#xf8;ndelag Hospital Trust, Namsos, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myrberget</LastName><ForeName>Mari-Anne</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Clinical Services, St. Olav's University Hospital, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oseland</LastName><ForeName>Marit Sofie</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0002-6809-9313</Identifier><AffiliationInfo><Affiliation>Department of Social Work, Occupational Therapy and Physiotherapy, Hospital of Southern Norway, Kristiansand, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rens&#xe5;</LastName><ForeName>Marit Arnevik</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neurologic Clinic, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Revheim</LastName><ForeName>Tone</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Occupational Therapy, Orthopedic Clinic, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tysnes</LastName><ForeName>Ole-Bj&#xf8;rn</ForeName><Initials>OB</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neurologic Clinic, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>A&#xdf;mus</LastName><ForeName>J&#xf6;rg</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rekand</LastName><ForeName>Tiina</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-2506-9501</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Neurologic Clinic, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="Y">Cognition Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007802" MajorTopicYN="N">Language</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>4</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>4</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37141321</ArticleId><ArticleId IdType="pmc">PMC10159149</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0285307</ArticleId><ArticleId IdType="pii">PONE-D-22-05609</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Beeldman E, Raaphorst J, Twennaar M, deVisser M, Schmand B, de Haan R. The cognitive profile of ALS: a systematic review and meta-analysis update. J Neurol Neurosurg Psychiatry. 2015;87(6):611&#x2013;9. doi: 10.1136/jnnp-2015-310734</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310734</ArticleId><ArticleId IdType="pubmed">26283685</ArticleId></ArticleIdList></Reference><Reference><Citation>Raaphorst J, Beeldman E, De Visser M, De Haan R, Schmand B. A systematic review of behavioural changes in motor neuron disease. Amyotrophic lateral sclerosis: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2012;13(6):493&#x2013;501. doi: 10.3109/17482968.2012.656652</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.656652</ArticleId><ArticleId IdType="pubmed">22424127</ArticleId></ArticleIdList></Reference><Reference><Citation>Mioshi E, Caga J, Lillo P, Hsieh S, Ramsey E, Devenney E, et al.. Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival. Neurology. 2014;82(2):149&#x2013;55. doi: 10.1212/WNL.0000000000000023</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000023</ArticleId><ArticleId IdType="pubmed">24336140</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagnini F, Rossi G, Lunetta C, Banfi P, Castelnuovo G, Corbo M, et al.. Burden, depression, and anxiety in caregivers of people with amyotrophic lateral sclerosis. Psychol Health Med. 2010;15(6):685&#x2013;93. doi: 10.1080/13548506.2010.507773</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13548506.2010.507773</ArticleId><ArticleId IdType="pubmed">21154021</ArticleId></ArticleIdList></Reference><Reference><Citation>Olney R, Murphy J, Forwhew D, Garwood E, Miller B, Langmore S, et al.. The effects of executive and behavioral dysfunction on the course of ALS. Neurology. 2005;65:1774&#x2013;7. doi: 10.1212/01.wnl.0000188759.87240.8b</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000188759.87240.8b</ArticleId><ArticleId IdType="pubmed">16344521</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Phukan J, Bede P, Jordan N, Byrne S, Pender N, et al.. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology. 2011;76:1263&#x2013;69. doi: 10.1212/WNL.0b013e318214359f</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318214359f</ArticleId><ArticleId IdType="pubmed">21464431</ArticleId></ArticleIdList></Reference><Reference><Citation>Khin E, Minor D, Holloway A, Pelleg A. Decisional capacity in amyotrophic lateral sclerosis. J Am Acad Psychiatry Law. 2015;43:210&#x2013;7. .</Citation><ArticleIdList><ArticleId IdType="pubmed">26071511</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A, Chio A, Traynor B. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17(1):17&#x2013;23. doi: 10.1038/nn.3584</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong M, Abrahams S, Goldstein L, Woolley S, Mclauglin P, Snowden J, et al.. Amyotrophic lateral sclerosis&#x2014;frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler and Frontotemporal Degener. 2017;18:153&#x2013;74. doi: 10.1080/21678421.2016.1267768</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1267768</ArticleId><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Taule T, S&#xf8;vik M, Lein R, Wehling E, A&#xdf;mus J, Rekand T. Psychometric properties of cognitive assessment in amyotrophic lateral sclerosis: A systematic review. Patient Relat Outcome Meas. 2020;11:181&#x2013;94. doi: 10.2147/PROM.S256828</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/PROM.S256828</ArticleId><ArticleId IdType="pmc">PMC7519807</ArticleId><ArticleId IdType="pubmed">33061727</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon N, Goldstein L. Screening for cognitive and behavioral change in amyotrophic lateral sclerosis/motor neuron disease: a systematic review of validated screening methods. Amyotroph Lateral Scler and Frontotemporal Degener. 2018;20:1&#x2013;11. doi: 10.1080/21678421.2018.1530264</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1530264</ArticleId><ArticleId IdType="pubmed">30585510</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosselt IK, Nijboer TCW, Van Es MA. An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2020;21(5&#x2013;6):324&#x2013;36. doi: 10.1080/21678421.2020.1732424</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1732424</ArticleId><ArticleId IdType="pubmed">32157912</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye S, Li C, Liu X, Fan D. The Edinburgh cognitive and behavioural ALS screen in a Chinese amyotrophic lateral sclerosis population. PlosOne. 2016;11(5). doi: 10.1371/journal.pone.0155496</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0155496</ArticleId><ArticleId IdType="pmc">PMC4873026</ArticleId><ArticleId IdType="pubmed">27195772</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y, Ogino M, Ichikawa H, Hanajima R, Nakashima K. The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) for Japanese ALS and FTD patients. Amyotrophic lateral sclerosis &amp; frontotemporal degeneration. 2021;1&#x2013;2:66&#x2013;72. doi: 10.1080/21678421.2020.1801751</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1801751</ArticleId><ArticleId IdType="pubmed">32757854</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezd&#xed;&#x10d;ek O, Markov&#xe1; L, So&#xf3;sov&#xe1; N, Forg&#xe1;&#x10d; M. Czech version of the Edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen&#x2013;a pilot study. Cesk Slov Neurol N. 2018;81(2):208&#x2013;12. doi: 10.14735/amcsnn2018208</Citation><ArticleIdList><ArticleId IdType="doi">10.14735/amcsnn2018208</ArticleId></ArticleIdList></Reference><Reference><Citation>Kourtesis P, Christidi F, Margioti E, Demenega C, Renzos M, Evdokimidis I, et al.. The Edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen (ECAS): sensitivity in differentiating between ALS and Alzheimer&#x2019;s disease in a Greek population. Amyotroph Lateral Scler and Frontotemporal Degener. 2019;30:1&#x2013;8. doi: 10.1080/21678421.2019.1655059</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1655059</ArticleId><ArticleId IdType="pubmed">31469297</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, Burkhardt C, Abdulla S, B&#xf6;hm S, Kollewe K, Uttner I, et al.. The Edinburgh cognitive and behavioural amyotrophic lateral sclerosis screen: a cross-sectional comparison of established screening tools in a German-Swiss population. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(1&#x2013;2):16&#x2013;23. doi: 10.3109/21678421.2014.959451</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.959451</ArticleId><ArticleId IdType="pubmed">25292386</ArticleId></ArticleIdList></Reference><Reference><Citation>Loose M, Burkhardt C, Aho-&#xd6;zhan H, Keller J, Abdulla S, B&#xf4;hm S, et al.. Age and education-matched cut-off scores for the revised German/Swiss-German version of ECAS. Amyotroph Lateral Scler and Frontotemporal Degener. 2016;17(5&#x2013;6). doi: 10.3109/21678421.2016.1162814</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1162814</ArticleId><ArticleId IdType="pubmed">27027323</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora J, Salas T, Fern&#xe1;ndez M, Rodriguez-Castillo V, Chaverri D, Rodriguez-Santos F. Spanish adaptation of the Edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen (ECAS). Amyotroph Lateral Scler and Frontotemporal Degener. 2018;19(1&#x2013;2):74&#x2013;9. doi: 10.1080/21678421.2017.1406952</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1406952</ArticleId><ArticleId IdType="pubmed">29212378</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Solca F, Carelli L, Faini A, Madotto F, Lafronza A, et al.. Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh cognitive and behavioral ALS screen (ECAS). Amyotroph Lateral Scler and Frontotemporal Degener. 2018;19:387&#x2013;95. doi: 10.1080/21678421.2018.1473443</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1473443</ArticleId><ArticleId IdType="pubmed">29804470</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Solca F, Carelli L, Madotto F, Lafronza A, Faini A, et al.. The validation of the Italian Edinburgh cognitive and behavioural ALS screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(7&#x2013;8):489&#x2013;98. doi: 10.1080/21678421.2016.1183679</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1183679</ArticleId><ArticleId IdType="pubmed">27219526</ArticleId></ArticleIdList></Reference><Reference><Citation>Siciliano M, Trojano L, Trojsi F, Greco R, Santoro M, Basile G, et al.. Edinburgh Cognitive and Behavioural ALS Screen (ECAS)-Italian version: regression based norms and equivalent scores. Neurol Sci. 2017;38:1059&#x2013;68. doi: 10.1007/s10072-017-2919-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-017-2919-4</ArticleId><ArticleId IdType="pubmed">28332040</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakker LA, Schr&#xf6;der CD, Spreij LA, Verhaegen M, De Vocht J, Van Damme P, et al.. Derivation of norms for the Dutch version of the Edinburgh cognitive and behavioral ALS screen. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2019;20(1&#x2013;2):19&#x2013;27. doi: 10.1080/21678421.2018.1522352</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1522352</ArticleId><ArticleId IdType="pubmed">30314420</ArticleId></ArticleIdList></Reference><Reference><Citation>Taule T, Morland A, A&#xdf;mus J, Tysnes O, Rekand T. Translation, cultural adaptation, and validation of a screening test for cognitive and behavioural changes in amyotrophic lateral sclerosis. Disabil Rehabil. 2021:1&#x2013;9. doi: 10.1080/09638288.2021.1980621</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638288.2021.1980621</ArticleId><ArticleId IdType="pubmed">34726988</ArticleId></ArticleIdList></Reference><Reference><Citation>Streiner D, Norman G, Cairney J. Health measurement scales. A practical guide to their development and use. 5th ed: Oxford University Press; 2015. 399 p.</Citation></Reference><Reference><Citation>Mokkink L, Terwee C, Patrick D, Alonso J, Stratford P, Knol D, et al.. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19(4):539&#x2013;49. doi: 10.1007/s11136-010-9606-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-010-9606-8</ArticleId><ArticleId IdType="pmc">PMC2852520</ArticleId><ArticleId IdType="pubmed">20169472</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Newton J, Niven E, Foley G, Bak T. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler and Frontotemporal Degener. 2014;15(1&#x2013;2):9&#x2013;14. doi: 10.3109/21678421.2013.805784</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.805784</ArticleId><ArticleId IdType="pubmed">23781974</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine ZS, Phillips NA, B&#xe8;dirian V, Charbonneau S, Whitehead V, Collin I, et al.. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695&#x2013;9. doi: 10.1111/j.1532-5415.2005.53221.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman D, Egger M, Pocock S, G&#xe6;tzsche P, Vandenbroucke J. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. PloS Med. 2007;4(10):e296. doi: 10.1371/journal.pmed.0040296</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0040296</ArticleId><ArticleId IdType="pmc">PMC2020495</ArticleId><ArticleId IdType="pubmed">17941714</ArticleId></ArticleIdList></Reference><Reference><Citation>Arafat Y. Validation study can be a separate study design. Int J Med Sci Public Health. 2015;5(11):1&#x2013;2. doi: 10.5455/ijmsph.2016.19042016471</Citation><ArticleIdList><ArticleId IdType="doi">10.5455/ijmsph.2016.19042016471</ArticleId></ArticleIdList></Reference><Reference><Citation>Taule T AS. M, Rens&#xe5; M, A&#xdf;mus J, Tysnes O, Rekand T. Edinburgh cognitive and behavioural amyotrophic lateral sclerosis screen (ECAS) in Norway: Protocol for validation and a prospective cohort study. Contemp Clin Trials Commun. 2019;14. doi: 10.1016/j.conctc.2019.100347</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conctc.2019.100347</ArticleId><ArticleId IdType="pmc">PMC6444026</ArticleId><ArticleId IdType="pubmed">30976725</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolea M, Galvin J. Current guidelines for dementia screening: a shortcomings and recommended changes. Neurodegen Dis Manage. 2013;3(6):565&#x2013;73. doi: 10.2217/nmt.13.58</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nmt.13.58</ArticleId><ArticleId IdType="pmc">PMC4140653</ArticleId><ArticleId IdType="pubmed">25152772</ArticleId></ArticleIdList></Reference><Reference><Citation>Taule T, S&#xf8;vik M, Lein R, Wehling E, A&#xdf;mus J, Rekand T. Cognitive assessment tools used in ALS-specific health-care: A systematic review of their psychometric properties: PROSPERO: International prospective register of systematic reviews; 2017. Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017055603.</Citation></Reference><Reference><Citation>Sousa V, Rojjanasrirat W. Translation, adaptation and validation of instruments or scales for use in cross-cultural health care research: a clear and user-friendly guideline. Journal of evaluation in clinical practice. 2011;17(2):268&#x2013;74. doi: 10.1111/j.1365-2753.2010.01434.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2753.2010.01434.x</ArticleId><ArticleId IdType="pubmed">20874835</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborne RA, Sekhon R, Johnston W, Kalra S. Screening for frontal lobe and general cognitive impairment in patients with amyotrophic lateral sclerosis. Journal of the neurological sciences. 2014;336(1&#x2013;2):191&#x2013;6. doi: 10.1016/j.jns.2013.10.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2013.10.038</ArticleId><ArticleId IdType="pubmed">24239183</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhardt C, Neuwirth C, Weber M. Longitudinal assessment of the Edinburgh cognitive and behavioural amyotrophic lateral sclerosis screen (ECAS): lack of practice effect in ALS patients? Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(3&#x2013;4):202&#x2013;9. doi: 10.1080/21678421.2017.1283418</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1283418</ArticleId><ArticleId IdType="pubmed">28165766</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke T, Wynne B, O&#x2019;Brien C, Elamin M, Bede P, Hardiman O, et al.. Retrospective investigations of practice effects on repeated neuropsychological measures of executive functioning. The Irish Journal of Psychology. 2014;35(4):178&#x2013;87. doi: 10.1080/03033910.2015.1044554</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03033910.2015.1044554</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Bak T. Edinburgh Cognitive and Behavioural ALS Screen&#x2014;ECAS English version 2013 Edinburgh Research Archive: The University of Edinburgh; 2013.  [cited 2015 2015.04.28]. Available from: https://www.era.lib.ed.ac.uk/handle/1842/6592.</Citation></Reference><Reference><Citation>Terwee C, Bot S, de Boer M, van der Windt D, Knol D, Dekker J, et al.. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34&#x2013;42. doi: 10.1016/j.jclinepi.2006.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2006.03.012</ArticleId><ArticleId IdType="pubmed">17161752</ArticleId></ArticleIdList></Reference><Reference><Citation>SPSS. IBM SPSS Statistics for Windows, Version 26.0. Amonk, NY: IBM Corp.; 2019.</Citation></Reference><Reference><Citation>Matlab. Matlab, Version 9.0. Natick, MA: The MathWorks; Inc; 2016.</Citation></Reference><Reference><Citation>McGraw K, Wing S. Forming inferences about some intraclass correlation coefficients. Psychol Methods. 1996;1:30&#x2013;46. doi: org/10.1037/1082-989X.1.1.30</Citation></Reference><Reference><Citation>Koo T, Li M. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016;15(2):155&#x2013;63. doi: 10.1016/j.jcm.2016.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcm.2016.02.012</ArticleId><ArticleId IdType="pmc">PMC4913118</ArticleId><ArticleId IdType="pubmed">27330520</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J. A coefficient of agreement for nominale scales. Educ Psychol Meas. 1960;20(1):37&#x2013;46. doi: 10.1177/001316446002000104</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/001316446002000104</ArticleId></ArticleIdList></Reference><Reference><Citation>Bland JM, Altman DG. Measuring agreement in method comparison studies. Statistical methods in medical research. 1999;8(2):135&#x2013;60. doi: 10.1177/096228029900800204</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096228029900800204</ArticleId><ArticleId IdType="pubmed">10501650</ArticleId></ArticleIdList></Reference><Reference><Citation>Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307&#x2013;10. .</Citation><ArticleIdList><ArticleId IdType="pubmed">2868172</ArticleId></ArticleIdList></Reference><Reference><Citation>Kottner J, Audig&#xe9; L, Brorson S, Donner A, Gajewski BJ, Hr&#xf3;bjartsson A, et al.. Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed. Journal of clinical epidemiology. 2011;64(1):96&#x2013;106. doi: 10.1016/j.jclinepi.2010.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.03.002</ArticleId><ArticleId IdType="pubmed">21130355</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin S, Nelson L, McLeod L, Eremenco S, Coons S. Assessing test&#x2013;retest reliability of patient-reported outcome measures using intraclass correlation coefficients: recommendations for selecting and documenting the analytical formula. Quality of Life Research. 2019;28:1029&#x2013;33. doi: 10.1007/s11136-018-2076-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-018-2076-0</ArticleId><ArticleId IdType="pmc">PMC6439259</ArticleId><ArticleId IdType="pubmed">30547346</ArticleId></ArticleIdList></Reference><Reference><Citation>World Medical Association. World medical association declaration of Helsinki&#x2014;Ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191&#x2013;4. doi: 10.1001/jama.2013.281053</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.281053</ArticleId><ArticleId IdType="pubmed">24141714</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakken O, Lindstr&#xf8;m J, Tysnes O, Holm&#xf8;y T. Mortality trends of amyotrophic lateral sclerosis in Norway 1951&#x2013;2014: an age-period-cohort study. J Neurol. 2016;263(12):2378&#x2013;85. doi: 10.1007/s00415-016-8273-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-016-8273-2</ArticleId><ArticleId IdType="pubmed">27586392</ArticleId></ArticleIdList></Reference><Reference><Citation>Taber K. The Use of Cronbach&#x2019;s AlphaWhen Developing and Reporting Research Instruments in Science Education. Res Sci Educ. 2018;48:1273&#x2013;96. doi: 10.1007/s11165-016-9602-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11165-016-9602-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Crockford C, Newton J, Lonergan K, Madden C, Mays I, O&#x2019;Sullivan M, et al.. Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotrophic lateral sclerosis &amp; frontotemporal degeneration. 2018;19(1&#x2013;2):65&#x2013;73. doi: 10.1080/21678421.2017.1407794</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1407794</ArticleId><ArticleId IdType="pmc">PMC6510059</ArticleId><ArticleId IdType="pubmed">29214872</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper E, Zydatiss K, Schuster C, Machts J, Bittner D, Kaufmann J, et al.. No Change in Executive Performance in ALS Patients: A Longitudinal Neuropsychological Study. Neurodegener Dis. 2016;16(3&#x2013;4):184&#x2013;91. doi: 10.1159/000440957</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000440957</ArticleId><ArticleId IdType="pubmed">26613522</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson KM, Lacey SC, Grugan P, Glosser G, Grossman M, McCluskey LF. Cognitive functioning in sporadic amyotrophic lateral sclerosis: a six month longitudinal study. J Neurol Neurosurg Psychiatry. 2006;77(5):668&#x2013;70. doi: 10.1136/jnnp.2005.073403</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2005.073403</ArticleId><ArticleId IdType="pmc">PMC2117453</ArticleId><ArticleId IdType="pubmed">16614030</ArticleId></ArticleIdList></Reference><Reference><Citation>Roalf D PJ. M, Xie S, Wolk D, Moelter S, SE A. Comparative accuracies of two common screening instruments for classification of Alzheimer&#x2019;s disease, mild cognitive impairment, and healthy aging. Alzheimers Dement. 2013;9(5):529&#x2013;37. doi: 10.1016/j.jalz.2012.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2012.10.001</ArticleId><ArticleId IdType="pmc">PMC4036230</ArticleId><ArticleId IdType="pubmed">23260866</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>